clevudine: Clinical Trials

6 trials of clevudine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 completed, 1 unknown. 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 3, Completed 2, Unknown 1

Follow clevudine: new trials by email Literature Review of clevudine trials Research Report on clevudine

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19
Clevudine, Placebo - COVID-19
Phase 2CompletedBukwang Pharmaceutical1042021-03-192022-07-22
The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19
Clevudine, Placebo - COVID-19
Phase 2CompletedBukwang Pharmaceutical642020-05-262022-07-22
Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201
Clevudine - Hepatitis B
Phase 2TerminatedBukwang Pharmaceutical332003-07-012017-02-01
Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group
Clevudine - Hepatitis B
Phase 2TerminatedBukwang Pharmaceutical2003-06-012012-10-17
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
clevudine (drug) - Hepatitis B
Phase 2UnknownTriangle Pharmaceuticals302002-08-012005-06-24
Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus
clevudine - Hepatitis B
Phase 2TerminatedBukwang Pharmaceutical1202002-07-012006-04-12

Conditions studied

Hepatitis B (4)  ·  COVID-19 (2)

Sponsors

Bukwang Pharmaceutical (5)  ·  Triangle Pharmaceuticals (1)

Countries

South Korea (5)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Singapore (1)  ·  United States (1)

Top investigators

Hyo Suk Lee, M.D., Ph.D. (3)  ·  Woo-Joo Kim, M.D.,Ph.D. (1)

Results publications

PMID 16628625